CAPTRUST Financial Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,621
Closed -$308K 2736
2023
Q3
$308K Buy
9,621
+26
+0.3% +$1K ﹤0.01% 1979
2023
Q2
$421K Sell
9,595
-1,990
-17% -$91.8K ﹤0.01% 1717
2023
Q1
$513K Buy
11,585
+2,187
+23% +$96.7K ﹤0.01% 1391
2022
Q4
$373K Buy
9,398
+3,196
+52% +$133K ﹤0.01% 1498
2022
Q3
$286K Buy
6,202
+2,076
+50% +$102K ﹤0.01% 1580
2022
Q2
$178K Buy
4,126
+1,826
+79% +$83.5K ﹤0.01% 1774
2022
Q1
$124K Sell
2,300
-2
-0.1% -$102 ﹤0.01% 2106
2021
Q4
$138K Sell
2,302
-35
-1% -$2.18K ﹤0.01% 1921
2021
Q3
$153K Sell
2,337
-2,000
-46% -$130K ﹤0.01% 1745
2021
Q2
$274K Sell
4,337
-914
-17% -$52.5K ﹤0.01% 1327
2021
Q1
$256K Buy
5,251
+2,201
+72% +$106K ﹤0.01% 1315
2020
Q4
$126K Sell
3,050
-23
-0.7% -$1.05K ﹤0.01% 1399
2020
Q3
$143K Hold
3,073
﹤0.01% 1186
2020
Q2
$136K Buy
+3,073
New +$138K ﹤0.01% 1201

Other funds holding KIDS

CAPTRUST Financial Advisors's KIDS Position: Q4 2023 in Review

CAPTRUST Financial Advisors sold out of OrthoPediatrics (KIDS) in Q4 2023, closing a stake of 9,621 shares — an estimated $308K sold.

CAPTRUST Financial Advisors first reported a position in KIDS in Q2 2020 and held it in 14 quarters. The position peaked at $513K in Q1 2023. 129 funds tracked by Wall St. Rank hold KIDS as of Q4 2023.

  • CAPTRUST Financial Advisors reported no remaining OrthoPediatrics position as of Q4 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 9,621 OrthoPediatrics shares in Q4 2023, an estimated $308K.
  • CAPTRUST Financial Advisors first reported a position in OrthoPediatrics in Q2 2020 and held it in 14 quarters.
  • CAPTRUST Financial Advisors's OrthoPediatrics position peaked at $513K in Q1 2023.
  • 129 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.